{"entity":{"type":"insider","cik":"0001769331","url":"/insider/0001769331","json_url":"/insider/0001769331.json","name":"Arthur David J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":5,"first":"2020-02-12","last":"2022-05-31","span_basis":"filed_date"},"name_variants":[{"name":"Arthur David J.","source":"filing","n_filings":5,"first_seen":"2020-02-12","last_seen":"2022-05-31"}],"transactions":[{"id":6377332,"accession":"0001615219-22-000087","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001615219-22-000087","line_url":"/filing/0001615219-22-000087","is_derivative":false,"issuer_cik":"0001615219","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001615219","owner_cik":"0001769331","owner_name":"Arthur David J.","owner_display_name":"Arthur David J.","owner_url":"/insider/0001769331","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43900.0,"shares_display":"43,900","price_per_share":0.18188156719817766,"price_display":"0.18","price_state":"stated","total_value":7984.6008,"total_display":"7,984.60","total_whole":"7,985","shares_owned_after":281674.0,"shares_owned_after_display":"281,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider","n_lines":5},{"id":6256434,"accession":"0001615219-22-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001615219-22-000018","line_url":"/filing/0001615219-22-000018#line-1","is_derivative":false,"issuer_cik":"0001615219","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001615219","owner_cik":"0001769331","owner_name":"Arthur David J.","owner_display_name":"Arthur David J.","owner_url":"/insider/0001769331","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":139488.0,"shares_display":"139,488","price_per_share":0.391,"price_display":"0.39","price_state":"stated","total_value":54539.808,"total_display":"54,539.81","total_whole":"54,540","shares_owned_after":249674.0,"shares_owned_after_display":"249,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-09","scope":"insider"},{"id":5078648,"accession":"0001615219-21-000087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615219-21-000087","line_url":"/filing/0001615219-21-000087","is_derivative":false,"issuer_cik":"0001615219","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001615219","owner_cik":"0001769331","owner_name":"Arthur David J.","owner_display_name":"Arthur David J.","owner_url":"/insider/0001769331","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":0.8955,"price_display":"0.90","price_state":"stated","total_value":3582.0,"total_display":"3,582.00","total_whole":"3,582","shares_owned_after":100247.0,"shares_owned_after_display":"100,247","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-17","scope":"insider","n_lines":2},{"id":2874163,"accession":"0001615219-20-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001615219-20-000095","line_url":"/filing/0001615219-20-000095","is_derivative":false,"issuer_cik":"0001615219","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001615219","owner_cik":"0001769331","owner_name":"Arthur David J.","owner_display_name":"Arthur David J.","owner_url":"/insider/0001769331","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":2020.0,"total_display":"2,020.00","total_whole":"2,020","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-20","scope":"insider","n_lines":2},{"id":2772099,"accession":"0000899243-20-004413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-004413","line_url":"/filing/0000899243-20-004413#line-1","is_derivative":false,"issuer_cik":"0001615219","issuer_name":"Salarius Pharmaceuticals, Inc.","issuer_ticker":"SLRX","issuer_name_source":null,"issuer_url":"/issuer/0001615219","owner_cik":"0001769331","owner_name":"Arthur David J.","owner_display_name":"Arthur David J.","owner_url":"/insider/0001769331","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2175.0,"shares_display":"2,175","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":2501.25,"total_display":"2,501.25","total_whole":"2,501","shares_owned_after":81546.0,"shares_owned_after_display":"81,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001615219","name":"Salarius Pharmaceuticals, Inc.","url":"/issuer/0001615219","role":"Director, Officer (Chief Executive Officer)","n_filings":5,"first_seen":"2020-02-12","last_seen":"2022-05-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001769331","retrieved_at":"2026-08-23T11:39:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}